SCP
TAK icon

Sivia Capital Partners’s Takeda Pharmaceutical TAK Stock Holding History

Sivia Capital Partners’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
64,459
+29,699
+85% +$491K 0.13% 189
2026
Q1 		$644K Buy
34,760
+12,470
+56% +$219K 0.12% 215
2025
Q4 		$348K Sell
22,290
-9,259
-29% -$132K 0.07% 367
2025
Q3 		$462K Buy
31,549
+8,815
+39% +$131K 0.13% 195
2025
Q2 		$351K Buy
+22,734
New +$336K 0.12% 224

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Sivia Capital Partners's TAK Position: Q2 2026 in Review

Sivia Capital Partners increased its Takeda Pharmaceutical (TAK) stake by 85% in Q2 2026, buying an estimated $491K and bringing the position to 64,459 shares worth $1.03M. The position accounts for 0.13% of the portfolio, ranked #189.

Sivia Capital Partners first reported a position in TAK in Q2 2025 and has held it in 5 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Sivia Capital Partners held 64,459 shares of Takeda Pharmaceutical worth $1.03M as of Q2 2026.
  • Sivia Capital Partners bought 29,699 Takeda Pharmaceutical shares in Q2 2026, an estimated $491K.
  • Takeda Pharmaceutical made up 0.13% of Sivia Capital Partners's portfolio in Q2 2026, its #189 holding.
  • Sivia Capital Partners first reported a position in Takeda Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.